Health Care

Nestle Faces Government Action Over Sugar Levels In Infant Food: Report
|The action follows a report by Public Eye, which accused the FMCG giant of adding more sugar and honey to its infant milk and cereal products in developing countries like India.
Why Nestle India Stock Just Marked Its Steepest Drop In Three Years
|Nestle India shares were trading 3.38% lower at ₹2,459.95 at midday on Thursday. The stock has fallen 10% so far this year, compared to a 2% rise in the benchmark Nifty 50.
Google And Apollo To Provide 3M Free AI Screenings For Life-Threatening Diseases
|Google is partnering with Apollo Radiology International to bring AI to early disease detection in India, aiming to improve healthcare accessibility and quality.
Supreme Court Issues Temporary Ban On Patanjali's 'Misleading' Ads
|The Supreme Court has taken action against Patanjali Ayurved and its managing director for circulating misleading advertisements about medicinal remedies.
Paytm Staffer Tragically Ends Life Amid Job Security Fears
|This comes in the wake of recent regulatory actions by the Reserve Bank of India (RBI), which has imposed restrictions on PPBL.
No More Cheesy Business: FDA Tells McDonald's After Finding Use Of Cheap Substitutes
|The issue came to light in October when inspectors at McDonald's Kedgaon branch found products containing cheese analogues.
L&T Tech Shares Climb On Fresh Collaboration With NVIDIA
|L&T Technology Services Ltd. shares were trading 1.47% higher at ₹4,519.20 on Monday morning.
Cipla Pioneers Drone-Delivered Medicine To Remote Areas In Himachal Pradesh
|The drone delivery project is primarily focused on cardiac and respiratory treatments and other key chronic therapies.
How A Small Hyderabad Firm Found Itself In A U.S. Lawsuit Against Big Pharma
|Few may have expected Hyderabad-based Natco Pharma, to be dragged into a case that involves pharma giants like Bristol-Myers Squibb and Teva International, the formula for a cancer drug and the alleged hoodwinking of the U.S. judicial system.
This Azim Premji-Backed Large Cap Stock Is Gaining On US FDA Drug Approval
|The Indian pharmaceutical giant on Tuesday received approval from the US Food and Drug Administration to market its generic Pirfenidone capsules for the treatment of idiopathic pulmonary fibrosis, a lung disease.
Pharma Giant Cipla Explores Billion-Dollar Stake Sale To Blackstone, Baring Asia: Report
|The move is seen as a step towards succession planning for the pharma major.
Cipla Recalls Six Batches Of Inhaler In The US Over Container Defect
|Indian pharmaceutical company Cipla has announced that its US unit is recalling six batches of albuterol sulfate inhalation aerosol due to a container defect.
PharmEasy Parent Set To Secure Significant Funding Amid Debt Challenges
|Manipal Group is considering an investment of approximately ₹1,000 crore for an 18% stake in API Holdings. As part of this potential deal, Manipal Group may also earn a seat on the API Holdings' board.
Cyberattack Hits Paracetamol Maker's Revenue And Profit, Shares Fall
|While the group said it had acted "decisively" to keep the damage in check, the attack has severely affected its business operations, requiring extensive changes to IT systems and additional time to meet regulatory requirements and ensure quality production.
Toxic Ingredients In Marion Biotech's Cough Syrups May Have Led To Tragedy In Uzbekistan
|This incident is part of a larger issue involving contaminated cough syrups from India causing deaths in other countries. The international inquiry into the pharmaceutical supply chain prompted Gambia to impose restrictions on Indian exports.
Why This Ashish Dhawan-Backed Pharma Stock Is Tanking Today
|The warning is given to a firm when used when regulatory agencies find important rule violations during their inspections or investigations.
Lenskart Gets Eye-Catching $100M Funding Boost From ChrysCapital
|Lenskart's future plans include the establishment of a new factory to manufacture and ship 20 million pairs of eyewear next year.
Bill Gates Heaps Praises On PM Modi For Mann Ki Baat: 'Has Catalyzed Community Led Action'
|Bill Gates, Microsoft co-founder and the world's fourth richest person, on Saturday, heaped praises on Prime Minister Narendra Modi as the latter's monthly radio program Mann Ki Baat completed its 100th episode.
Essential Medicines' Prices To Rise By 12%: What's Forcing The Record Hike?
© 2024 Benzinga | All Rights Reserved